{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:56:36Z","timestamp":1786132596156,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ando.2026.102588","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:28:22Z","timestamp":1784179702000},"page":"102588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of automated insulin delivery after recent pump therapy initiation in type 1 diabetes"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3407-7263","authenticated-orcid":false,"given":"Eric","family":"Renard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Halbron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salha","family":"Fendri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9856-5859","authenticated-orcid":false,"given":"Ga\u00e9tan","family":"Prevost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Briet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis","family":"Chartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Farret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-1425","authenticated-orcid":false,"given":"Orianne","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2026.102588_bib0130","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2026.102588_bib0135","doi-asserted-by":"crossref","first-page":"e3430","DOI":"10.1002\/dmrr.3430","article-title":"The SAGE study: global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM","volume":"37","author":"Renard","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ando.2026.102588_bib0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00592-022-01929-5","article-title":"Automated insulin delivery systems: from early research to routine care of type 1 diabetes","volume":"60","author":"Renard","year":"2023","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ando.2026.102588_bib0145","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2026.102588_bib0150","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","article-title":"Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial","volume":"392","author":"Tauschmann","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2026.102588_bib0155","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S2589-7500(19)30003-2","article-title":"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial","volume":"1","author":"Benhamou","year":"2019","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.ando.2026.102588_bib0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2026.102588_bib0165","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2337\/dc20-1809","article-title":"Diabeloop DBLG1 closed-loop system enables patients with type 1 diabetes to significantly improve their glycemic control in real-life situations without serious adverse events: 6-month follow-up","volume":"44","author":"Amadou","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2026.102588_bib0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/dom.13933","article-title":"Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes","volume":"22","author":"Akturk","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ando.2026.102588_bib0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/dia.2020.0388","article-title":"Real-world patient-reported outcomes and glycemic results with initiation of Control-IQ technology","volume":"23","author":"Pinsker","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.ando.2026.102588_bib0180","doi-asserted-by":"crossref","first-page":"101206","DOI":"10.1016\/j.diabet.2020.10.004","article-title":"Practical implementation of automated closed-loop insulin delivery: a French position statement","volume":"47","author":"Tubiana-Rufi","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ando.2026.102588_bib0185","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/dme.13930","article-title":"Assessing patient-reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures","volume":"36","author":"Weissberg-Benchell","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.ando.2026.102588_bib0190","doi-asserted-by":"crossref","first-page":"k1310","DOI":"10.1136\/bmj.k1310","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis","volume":"361","author":"Bekiari","year":"2018","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ando.2026.102588_bib0195","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1089\/dia.2025.0165","article-title":"Hybrid closed-loop therapy in adults with type 1 diabetes in England: long-Term outcomes from a real-world observational study","volume":"27","author":"Liarakos","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.ando.2026.102588_bib0200","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1089\/dia.2023.0414","article-title":"12-month real-life efficacy of the MiniMed 780G advanced closed-loop system in patients living with type 1 diabetes: a French observational, retrospective, multicentric study","volume":"26","author":"Lablanche","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.ando.2026.102588_bib0205","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/dia.2021.0097","article-title":"One year real-world use of the Control-IQ advanced hybrid closed-loop technology","volume":"23","author":"Breton","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.ando.2026.102588_bib0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00592-020-01607-4","article-title":"One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes","volume":"58","author":"Petrovski","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ando.2026.102588_bib0215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery (AID) technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2026.102588_bib0220","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2026.102588_bib0225","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2337\/dc14-0920","article-title":"Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study","volume":"38","author":"Khunti","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2026.102588_bib0230","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/dom.15462","article-title":"The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes","volume":"26","author":"Reznik","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.ando.2026.102588_bib0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/dia.2024.0315","article-title":"Evaluation of an automated priming bolus for improving prandial glucose control in full closed loop delivery","volume":"27","author":"Moscoso-Vasquez","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.ando.2026.102588_bib0240","unstructured":"Unobtrusive continuous multi-metabolite monitoring for a physiological care of insulin-treated diabetes. https:\/\/music4diabetes.eu."},{"key":"10.1016\/j.ando.2026.102588_bib0245","doi-asserted-by":"crossref","first-page":"101637","DOI":"10.1016\/j.diabet.2025.101637","article-title":"Practical implementation of automated insulin delivery systems in 2025: a French position statement update","volume":"51","author":"Bismuth","year":"2025","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ando.2026.102588_bib0250","series-title":"Syst\u00e8mes de mesure du glucose interstitiel, coupl\u00e9s ou non \u00e0 une pompe \u00e0 insuline et syst\u00e8mes de boucle semi-ferm\u00e9e pour la gestion automatis\u00e9e du diab\u00e8te","year":"2024"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:21:34Z","timestamp":1786130494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426626001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0003426626001095"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2026.102588","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of automated insulin delivery after recent pump therapy initiation in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2026.102588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102588"}}